• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 CRISPR/Cas9 筛选鉴定 DAXX 为 SARS-CoV-2 的限制因子。

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.

机构信息

Institut Pasteur, Université de Paris Cité, CNRS UMR 3569, Viral populations and pathogenesis Unit, F-75015, Paris, France.

Institut de Recherche en Infectiologie de Montpellier (IRIM), , Université de Montpellier, CNRS, 34090, Montpellier, France.

出版信息

Nat Commun. 2022 May 4;13(1):2442. doi: 10.1038/s41467-022-30134-9.

DOI:10.1038/s41467-022-30134-9
PMID:35508460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9068693/
Abstract

Interferon restricts SARS-CoV-2 replication in cell culture, but only a handful of Interferon Stimulated Genes with antiviral activity against SARS-CoV-2 have been identified. Here, we describe a functional CRISPR/Cas9 screen aiming at identifying SARS-CoV-2 restriction factors. We identify DAXX, a scaffold protein residing in PML nuclear bodies known to limit the replication of DNA viruses and retroviruses, as a potent inhibitor of SARS-CoV-2 and SARS-CoV replication in human cells. Basal expression of DAXX is sufficient to limit the replication of SARS-CoV-2, and DAXX over-expression further restricts infection. DAXX restricts an early, post-entry step of the SARS-CoV-2 life cycle. DAXX-mediated restriction of SARS-CoV-2 is independent of the SUMOylation pathway but dependent on its D/E domain, also necessary for its protein-folding activity. SARS-CoV-2 infection triggers the re-localization of DAXX to cytoplasmic sites and promotes its degradation. Mechanistically, this process is mediated by the viral papain-like protease (PLpro) and the proteasome. Together, these results demonstrate that DAXX restricts SARS-CoV-2, which in turn has evolved a mechanism to counteract its action.

摘要

干扰素可限制细胞培养中的 SARS-CoV-2 复制,但目前仅鉴定出少数具有抗 SARS-CoV-2 活性的干扰素刺激基因。在这里,我们描述了一个功能性的 CRISPR/Cas9 筛选,旨在鉴定 SARS-CoV-2 的限制因子。我们发现,DAXX 是一种支架蛋白,位于 PML 核小体中,已知其可限制 DNA 病毒和逆转录病毒的复制,是一种有效的 SARS-CoV-2 和 SARS-CoV 复制抑制剂。DAXX 的基础表达足以限制 SARS-CoV-2 的复制,而过表达 DAXX 则进一步限制感染。DAXX 限制了 SARS-CoV-2 生命周期的早期、进入后阶段。DAXX 介导的 SARS-CoV-2 限制不依赖于 SUMOylation 途径,但依赖于其 D/E 结构域,这也是其蛋白折叠活性所必需的。SARS-CoV-2 感染会触发 DAXX 向细胞质部位重新定位,并促进其降解。从机制上讲,这一过程由病毒的 papain-like 蛋白酶(PLpro)和蛋白酶体介导。综上所述,这些结果表明,DAXX 限制了 SARS-CoV-2,而 SARS-CoV-2 则进化出了一种对抗其作用的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/b9d764d2d113/41467_2022_30134_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/9426b48b5753/41467_2022_30134_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/cb08364e2dcd/41467_2022_30134_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/87fd7f8e73df/41467_2022_30134_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/23c8d75a2126/41467_2022_30134_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/4b3b143861c2/41467_2022_30134_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/b9d764d2d113/41467_2022_30134_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/9426b48b5753/41467_2022_30134_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/cb08364e2dcd/41467_2022_30134_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/87fd7f8e73df/41467_2022_30134_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/23c8d75a2126/41467_2022_30134_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/4b3b143861c2/41467_2022_30134_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff48/9068693/b9d764d2d113/41467_2022_30134_Fig6_HTML.jpg

相似文献

1
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.通过 CRISPR/Cas9 筛选鉴定 DAXX 为 SARS-CoV-2 的限制因子。
Nat Commun. 2022 May 4;13(1):2442. doi: 10.1038/s41467-022-30134-9.
2
Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.人腺病毒感染细胞中病毒 E1B-55K 蛋白通过蛋白酶体依赖性降解 Daxx。
J Virol. 2010 Jul;84(14):7029-38. doi: 10.1128/JVI.00074-10. Epub 2010 May 19.
3
Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML.恒河猴疱疹病毒的病毒FGARAT同源物ORF75影响ND10成分SP100和PML的蛋白酶体降解。
J Virol. 2016 Aug 12;90(17):8013-28. doi: 10.1128/JVI.01181-16. Print 2016 Sep 1.
4
Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner.Daxx 通过依赖 SUMO 的方式抑制 HIV-1 逆转录和脱壳。
Viruses. 2020 Jun 11;12(6):636. doi: 10.3390/v12060636.
5
PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.PML 在 S 期被招募到异染色质中,并抑制 DAXX 介导的组蛋白 H3.3 染色质组装。
J Cell Sci. 2019 Mar 26;132(6):jcs220970. doi: 10.1242/jcs.220970.
6
The interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus.干扰素诱导的抗病毒蛋白 Daxx 对于干扰素介导的抗禽肉瘤病毒保护并非必需。
Virol J. 2014 May 28;11:100. doi: 10.1186/1743-422X-11-100.
7
High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication.由于鼠源癌细胞中 HSP25 水平低,导致 Daxx 水平升高,从而使腺病毒复制效率降低。
Exp Mol Med. 2019 Oct 15;51(10):1-20. doi: 10.1038/s12276-019-0321-4.
8
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.木瓜蛋白酶样蛋白酶调节新型冠状病毒2的病毒传播和固有免疫。
Nature. 2020 Nov;587(7835):657-662. doi: 10.1038/s41586-020-2601-5. Epub 2020 Jul 29.
9
E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.E1B-55K 介导的 RNF4 SUMO 靶向泛素连接酶的调节促进人腺病毒基因表达。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.00164-18. Print 2018 Jul 1.
10
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.

引用本文的文献

1
Glycosylphosphatidylinositol biosynthesis functions as a conserved host defense pathway against coronaviruses via regulation of LY6E.糖基磷脂酰肌醇生物合成通过对LY6E的调控,作为一种针对冠状病毒的保守宿主防御途径发挥作用。
PLoS Pathog. 2025 Sep 3;21(9):e1013441. doi: 10.1371/journal.ppat.1013441. eCollection 2025 Sep.
2
SARS-CoV-2 Nsp2 recruits GIGYF2 near viral replication sites and supports viral protein production.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白2(Nsp2)在病毒复制位点附近募集GIGYF2,并支持病毒蛋白的产生。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf674.
3
Identification of host cell surface proteins inhibiting furin dependent proteolytic processing of viral glycoproteins.

本文引用的文献

1
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.全基因组双向 CRISPR 筛选鉴定粘蛋白为调节 SARS-CoV-2 感染的宿主因子。
Nat Genet. 2022 Aug;54(8):1078-1089. doi: 10.1038/s41588-022-01131-x. Epub 2022 Jul 25.
2
Interferon resistance of emerging SARS-CoV-2 variants.新兴 SARS-CoV-2 变异株的干扰素耐药性。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203760119. doi: 10.1073/pnas.2203760119. Epub 2022 Jul 22.
3
Inference of CRISPR Edits from Sanger Trace Data.从 Sanger 测序数据推断 CRISPR 编辑。
鉴定抑制病毒糖蛋白弗林蛋白酶依赖性蛋白水解加工的宿主细胞表面蛋白。
Sci Rep. 2025 Jul 15;15(1):25454. doi: 10.1038/s41598-025-11164-x.
4
Regulation of viral replication by host restriction factors.宿主限制因子对病毒复制的调控。
Front Immunol. 2025 Jan 23;16:1484119. doi: 10.3389/fimmu.2025.1484119. eCollection 2025.
5
An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure.尽管接触了新冠病毒(SARS-CoV-2),但超早期、短暂的干扰素相关先天免疫反应与预防感染相关。
EBioMedicine. 2025 Jan;111:105475. doi: 10.1016/j.ebiom.2024.105475. Epub 2024 Dec 11.
6
A review of virus host factor discovery using CRISPR screening.利用 CRISPR 筛选技术进行病毒宿主因子发现的研究综述
mBio. 2024 Nov 13;15(11):e0320523. doi: 10.1128/mbio.03205-23. Epub 2024 Oct 18.
7
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.全基因组 CRISPR 敲除筛选发现 PLCSR1 是新冠病毒进入细胞的内在屏障,近期的病毒变异体已进化出抵抗该屏障的能力。
PLoS Biol. 2024 Sep 24;22(9):e3002767. doi: 10.1371/journal.pbio.3002767. eCollection 2024 Sep.
8
Interferon-stimulated genes and their antiviral activity against SARS-CoV-2.干扰素刺激基因及其对 SARS-CoV-2 的抗病毒活性。
mBio. 2024 Sep 11;15(9):e0210024. doi: 10.1128/mbio.02100-24. Epub 2024 Aug 22.
9
Genome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection.全基因组规模的CRISPR-Cas9筛选确定宿主因子为新冠病毒感染的潜在治疗靶点。
iScience. 2024 Jul 8;27(8):110475. doi: 10.1016/j.isci.2024.110475. eCollection 2024 Aug 16.
10
The antiviral state of the cell: lessons from SARS-CoV-2.细胞的抗病毒状态:来自 SARS-CoV-2 的启示。
Curr Opin Immunol. 2024 Apr;87:102426. doi: 10.1016/j.coi.2024.102426. Epub 2024 May 24.
CRISPR J. 2022 Feb;5(1):123-130. doi: 10.1089/crispr.2021.0113. Epub 2022 Feb 2.
4
Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.甜蜜的药物对抗有害的细菌:一种针对 DC-SIGN 介导的 SARS-CoV-2 传播的糖模拟策略。
J Am Chem Soc. 2021 Oct 27;143(42):17465-17478. doi: 10.1021/jacs.1c06778. Epub 2021 Oct 15.
5
A prenylated dsRNA sensor protects against severe COVID-19.一种类异戊二烯化双链 RNA 传感器可预防重症 COVID-19。
Science. 2021 Oct 29;374(6567):eabj3624. doi: 10.1126/science.abj3624.
6
DAXX represents a new type of protein-folding enabler.DAXX 代表了一种新型的蛋白质折叠促进剂。
Nature. 2021 Sep;597(7874):132-137. doi: 10.1038/s41586-021-03824-5. Epub 2021 Aug 18.
7
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.马替昔布是一种广谱冠状病毒 3CL 抑制剂,可阻断 SARS-CoV-2 的复制。
Science. 2021 Aug 20;373(6557):931-936. doi: 10.1126/science.abg5827. Epub 2021 Jul 20.
8
Functional landscape of SARS-CoV-2 cellular restriction.SARS-CoV-2 细胞限制的功能景观
Mol Cell. 2021 Jun 17;81(12):2656-2668.e8. doi: 10.1016/j.molcel.2021.04.008. Epub 2021 Apr 13.
9
Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19.严重急性呼吸综合征冠状病毒 2 型木瓜蛋白酶样蛋白酶与免疫系统的相互作用:COVID-19 治疗的潜在药物靶点。
Scand J Immunol. 2021 Oct;94(4):e13044. doi: 10.1111/sji.13044. Epub 2021 Aug 10.
10
ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.新冠病毒木瓜样蛋白酶可拮抗ISG15依赖的传感器MDA5激活,以逃避宿主固有免疫。
Nat Microbiol. 2021 Apr;6(4):467-478. doi: 10.1038/s41564-021-00884-1. Epub 2021 Mar 16.